4
Changes in Ownership
Lipocine Inc. Filed Acc 0001638599-20-000949
Chief Executive Officer sold 43,500 shares at $1.57 ($68,134)
- Chief Executive Officer acquired 267,978 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Mahesh V. Chief Executive Officer | 2020-12-04 | Option exercise | +145,000 | 1,118,612 | D | ||
| Patel Mahesh V. Chief Executive Officer | 2020-12-04 | Sale | −43,500 | $1.57 | $68,134 | 1,075,112 | D |
| Patel Mahesh V. Chief Executive Officer | 2020-12-05 | Option exercise | +122,978 | 1,198,090 | D | ||
| Derivatives | |||||||
| Patel Mahesh V. Chief Executive Officer | 2020-12-04 | Option exercise · Restricted Stock Unit | −145,000 | 145,000 | D | ||
| Patel Mahesh V. Chief Executive Officer | 2020-12-05 | Option exercise · Restricted Stock Unit | −122,978 | 122,978 | D | ||
| Open-market sales · 43,500 sh · avg $1.57 · $68,134 | |||||||
Loading xslF345X03/doc4_6948.xml…